 | Up a level |
Crotti, Lia; Neves, Raquel; Dagradi, Federica; Musu, Giulia; Giannetti, Federica; Bos, J Martijn; Barbieri, Miriam; Cerea, Paolo; Giovenzana, Fulvio L F; Torchio, Margherita; Mura, Manuela; Gnecchi, Massimiliano; Conte, Giulio; Auricchio, Angelo; Sala, Luca; Odening, Katja E; Ackerman, Michael J; Schwartz, Peter J (2024). Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients. Circulation, 150(7), pp. 531-543. American Heart Association 10.1161/CIRCULATIONAHA.124.068959
Giannetti, Federica; Barbieri, Miriam; Shiti, Assad; Casini, Simona; Sager, Philip T; Das, Saumya; Pradhananga, Sabindra; Srinivasan, Dinesh; Nimani, Saranda; Alerni, Nicolò; Louradour, Julien; Mura, Manuela; Gnecchi, Massimiliano; Brink, Paul; Zehender, Manfred; Koren, Gideon; Zaza, Antonio; Crotti, Lia; Wilde, Arthur A M; Schwartz, Peter J; ... (2023). Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2. Europace, 25(5) Oxford University Press 10.1093/europace/euad094
